VALIANTLAB Stock Overview
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Valiant Laboratories Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹157.30 |
| 52 Week High | ₹214.95 |
| 52 Week Low | ₹139.00 |
| Beta | 0 |
| 1 Month Change | 7.81% |
| 3 Month Change | -18.39% |
| 1 Year Change | n/a |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -7.61% |
Recent News & Updates
Recent updates
Shareholder Returns
| VALIANTLAB | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | -1.6% | 1.4% | 2.8% |
| 1Y | n/a | 57.2% | 46.6% |
Return vs Industry: Insufficient data to determine how VALIANTLAB performed against the Indian Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how VALIANTLAB performed against the Indian Market.
Price Volatility
| VALIANTLAB volatility | |
|---|---|
| VALIANTLAB Average Weekly Movement | 5.5% |
| Pharmaceuticals Industry Average Movement | 5.9% |
| Market Average Movement | 6.9% |
| 10% most volatile stocks in IN Market | 10.1% |
| 10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: VALIANTLAB's share price has been volatile over the past 3 months.
Volatility Over Time: VALIANTLAB's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1980 | 86 | Santosh Vora | valiantlabs.in |
Valiant Laboratories Limited operates as an active pharmaceutical ingredient/bulk drug manufacturing company in India and internationally. The company manufactures paracetamol in various grades, such as Indian/British/European/the United States pharmacopeias for the treatment of headaches, muscle aches, arthritis, back aches, toothaches, cold, and fever. It also offers specialty chemicals.
Valiant Laboratories Limited Fundamentals Summary
| VALIANTLAB fundamental statistics | |
|---|---|
| Market cap | ₹6.83b |
| Earnings (TTM) | ₹256.41m |
| Revenue (TTM) | ₹4.10b |
26.7x
P/E Ratio1.7x
P/S RatioIs VALIANTLAB overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| VALIANTLAB income statement (TTM) | |
|---|---|
| Revenue | ₹4.10b |
| Cost of Revenue | ₹3.52b |
| Gross Profit | ₹580.09m |
| Other Expenses | ₹323.69m |
| Earnings | ₹256.41m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 5.90 |
| Gross Margin | 14.16% |
| Net Profit Margin | 6.26% |
| Debt/Equity Ratio | 57.7% |
How did VALIANTLAB perform over the long term?
See historical performance and comparison